Re: Pharma Gets Fines All The TimeThe thing is Concordias balance sheet is on the brink. They just issued debt to pay debt when the business was tiring on all cylinders. The company is not in a good position to deal with further reduced cashflow from the UK bill, the class action lawsuits hitting the courts shortly or a Cma fine which could be up to 10% of global sales. Any one of these things could push the company over the edge. I wouldn't doubt we see the regulators open an investigation soon either. This will likely end up a delist.